Fluicell AB (FLUI) - Total Liabilities

Latest as of March 2026: Skr6.56 Million SEK ≈ $705.64K USD

Based on the latest financial reports, Fluicell AB (FLUI) has total liabilities worth Skr6.56 Million SEK (≈ $705.64K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Fluicell AB to track the company's year-over-year net asset growth rate.

Fluicell AB - Total Liabilities Trend (2014–2025)

This chart illustrates how Fluicell AB's total liabilities have evolved over time, based on quarterly financial data. See FLUI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Fluicell AB Competitors by Total Liabilities

The table below lists competitors of Fluicell AB ranked by their total liabilities.

Company	Country	Total Liabilities
Sagardeep Alloys Limited NSE:SAGARDEEP	India	Rs177.41 Million
Terra Uranium Ltd AU:T92	Australia	AU$495.56K
Catalina Resources Ltd AU:CTN	Australia	AU$1.60 Million
Pulse Oil Corp V:PUL	Canada	CA$6.87 Million
Raja Ferry Port Public Company Limited BK:RP	Thailand	฿613.87 Million
Green Ocean Corporation Bhd KLSE:0074	Malaysia	RM20.38 Million
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares NASDAQ:HKPD	USA	$4.43 Million
Dotz Nano Ltd F:57N	Germany	€5.51 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Fluicell AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see FLUI market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Fluicell AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Fluicell AB (2014–2025)

The table below shows the annual total liabilities of Fluicell AB from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr7.57 Million ≈ $815.08K	+20.72%
2024-12-31	Skr6.27 Million ≈ $675.18K	-29.62%
2023-12-31	Skr8.91 Million ≈ $959.40K	+7.15%
2022-12-31	Skr8.32 Million ≈ $895.36K	+5.72%
2021-12-31	Skr7.87 Million ≈ $846.94K	+47.60%
2020-12-31	Skr5.33 Million ≈ $573.81K	-45.10%
2019-12-31	Skr9.71 Million ≈ $1.05 Million	+273.54%
2018-12-31	Skr2.60 Million ≈ $279.80K	+33.13%
2017-12-31	Skr1.95 Million ≈ $210.17K	+109.10%
2016-12-31	Skr934.00K ≈ $100.51K	-7.71%
2015-12-31	Skr1.01 Million ≈ $108.91K	+108.76%
2014-12-31	Skr484.76K ≈ $52.17K	--

About Fluicell AB

ST:FLUI Sweden Biotechnology

Market Cap

$4.51 Million

Skr41.90 Million SEK

Market Cap Rank

#28743 Global

#651 in Sweden

Share Price

Skr30.50

Change (1 day)

-1.93%

52-Week Range

Skr7.95 - Skr57.20

All Time High

Skr188.78